ABVC BioPharma, Inc. (ABVC)
NASDAQ: ABVC · Real-Time Price · USD
2.850
+0.080 (2.89%)
At close: Sep 12, 2025, 4:00 PM EDT
2.880
+0.030 (1.05%)
After-hours: Sep 12, 2025, 6:37 PM EDT
ABVC BioPharma Market Cap
ABVC BioPharma has a market cap or net worth of $65.01 million as of September 12, 2025. Its market cap has increased by 638.77% in one year.
Market Cap
65.01M
Enterprise Value
66.73M
1-Year Change
638.77%
Ranking
Category
Stock Price
$2.85
Market Cap Chart
Since August 3, 2021, ABVC BioPharma's market cap has decreased from $79.50M to $65.01M, a decrease of -18.22%. That is a compound annual growth rate of -4.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 12, 2025 | 67.10M | 771.43% |
| Dec 31, 2024 | 7.70M | -8.33% |
| Dec 29, 2023 | 8.40M | -58.82% |
| Dec 30, 2022 | 20.40M | -78.97% |
| Dec 31, 2021 | 97.00M | 22.01% |
| Aug 3, 2021 | 79.50M | - |
View and export this data all the way back to 2021. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 678.14B |
| Johnson & Johnson | 428.83B |
| AbbVie | 385.71B |
| UnitedHealth Group | 319.26B |
| AstraZeneca | 247.84B |
| Novo Nordisk | 242.99B |
| Novartis AG | 240.09B |
| Abbott Laboratories | 232.75B |